Market Insights: AbCellera Biologics Inc (ABCL)’s Notable Drop of -0.41, Closing at 2.43

Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.

As of close of business last night, AbCellera Biologics Inc’s stock clocked out at $2.43, down -0.41% from its previous closing price of $2.44. In other words, the price has decreased by -$0.41 from its previous closing price. On the day, 5.77 million shares were traded. ABCL stock price reached its highest trading level at $2.5 during the session, while it also had its lowest trading level at $2.34.

Ratios:

To gain a deeper understanding of ABCL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.81 and its Current Ratio is at 9.81. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.06.

On February 22, 2024, The Benchmark Company Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $9.

On December 05, 2023, KeyBanc Capital Markets started tracking the stock assigning a Overweight rating and target price of $6.KeyBanc Capital Markets initiated its Overweight rating on December 05, 2023, with a $6 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABCL now has a Market Capitalization of 724110848 and an Enterprise Value of 163860032. For the stock, the TTM Price-to-Sale (P/S) ratio is 25.12 while its Price-to-Book (P/B) ratio in mrq is 0.68. Its current Enterprise Value per Revenue stands at 5.683 whereas that against EBITDA is -0.732.

Stock Price History:

The Beta on a monthly basis for ABCL is 0.43, which has changed by -0.38010204 over the last 52 weeks, in comparison to a change of 0.07455289 over the same period for the S&P500. Over the past 52 weeks, ABCL has reached a high of $4.34, while it has fallen to a 52-week low of $1.89. The 50-Day Moving Average of the stock is -6.38%, while the 200-Day Moving Average is calculated to be -12.37%.

Shares Statistics:

It appears that ABCL traded 4.22M shares on average per day over the past three months and 4795330 shares per day over the past ten days. A total of 295.76M shares are outstanding, with a floating share count of 223.58M. Insiders hold about 24.97% of the company’s shares, while institutions hold 37.05% stake in the company. Shares short for ABCL as of 1743379200 were 23624883 with a Short Ratio of 5.59, compared to 1740700800 on 19899185. Therefore, it implies a Short% of Shares Outstanding of 23624883 and a Short% of Float of 10.27.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Most Popular